Our Pipeline

Addressing High Unmet Medical Needs

Discovery Preclinical Phase 1 Phase 2 Phase 3
Details

BPD is a chronic severe lung disease primarily affecting extremely premature infants (< 28 weeks gestational age)  who require prolonged oxygen therapy to support their breathing. Prolonged mechanical ventilation can lead to inflammation and scarring of the lungs, which disrupts their normal development and repair. 

In developed countries, despite improved perinatal care, 40% of extremely preterm babies develop BPD, the most common and severe consequence of preterm birth. It remains the most common morbidity of prematurity*.

(*) Shah PS, Sankaran K, Aziz K, Allen AC, Seshia M, Ohlsson A, et al. Outcomes of preterm infants <29 weeks gestation over ten years in Canada: a cause for concern? J Perinatol. (2012) (https://pubmed.ncbi.nlm.nih.gov/21593814/)

Dermatology

Reproductive health

Details

Collaboration with Helse Bergen

Details

Servier and Exo Biologics enter into a collaboration agreement to evaluate the use of extracellular vesicles as a non-viral delivery vehicule for an undisclosed indication.

Our technology

Exosomes are small vesicles secreted by cells containing bioactive molecules, and they can be used for the targeted delivery of therapeutic agents.

Learn more
Logo ExoBiologics